Shot in the arm for cancer patients

AT least 380 disadvantaged breast cancer patients will receive a year-long free supply of tamoxifen, an oral drug used in treating breast cancer.

In 2018, the Zimbabwe National Cancer registry showed that breast cancer was the second most common malignancy diagnosed in Zimbabwean women after cervical cancer.

It accounted for about 10% of all cancers diagnosed in the country.

This story is for NewsDay subscribers.